Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

2 235 evidences · page 49 / 90

In all 10 initial cases with persistently discrepant rapid HIV test results, DNA polymerase chain reaction (PCR) was negative.

KenyaVIH/sidapublié 2021The Journal of infectious diseasesPubMeddocument de 3 observations

26 %Selection of HIV self-testing increased from 26% to 51% in the dynamic choice prevention arm.

KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 18 observations

Serum ALP activity was lower in HAART-experienced PWID compared to HIV-negative PWID (P = 0.048).

KenyaVIH/sidapublié 2024BMC infectious diseasesPubMeddocument de 10 observations

29 %1176 (29%) of the unsuppressed adolescents and young adults living with HIV in Kenya had a repeat viral load test within 6 months.

KenyaVIH/sidaobservé April 2017 to May 2019publié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations

78,9 %Among 223 virally unsuppressed clients aged 0–19 years on antiretroviral therapy enrolled in VDOT in Kenya between February 2021 and October 2022, 176 (78.9%) achieved viral suppression during follow-up.

KenyaVIH/sidaobservé February 2021 to October 2022publié 2025BMC infectious diseasesPubMeddocument de 10 observations

40 %Approximately 40% of the 110,000 adolescents living with HIV in Kenya have not achieved viral suppression.

KenyaVIH/sidapublié 2022BMC public healthPubMeddocument de 2 observations

4,8 log10 copies/mlAmong HIV-infected HHV-8 seropositive Kenyan women, those with CD4 count ≥500 cells/mm³ had a mean HHV-8 copy number of 4.8 log10 copies/ml, compared to 3.4 log10 copies/ml for those with CD4 count <500 cells/mm³.

KenyaHHV-8 · VIH/sidapublié 2014Journal of medical virologyeurope_pmcdocument de 5 observations

IL-4, IL-6, IL-10, TNF-α and TGF-β associated inversely with CD4 T cell counts and body mass index (BMI).

KenyaVIH/sidapublié 2021African health sciencesPubMeddocument de 5 observations

16 %At baseline, 16% of women with nonoptimal vaginal microbial community state type (CST-IV) had HIV.

KenyaVIH/sidapublié 2020Sexually transmitted diseasesPubMeddocument de 7 observations

68,9 %Among 911 women in the PrEP Implementation of Mothers in Antenatal Care trial in Kenya, 68.9% accepted HIV self-testing (HIVST).

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 11 observations

0,42 odds_ratioIn the secondary analysis, intervention adolescent girls and young women (AGYW) had fewer symptoms of depression than control AGYW, with an odds ratio of 0.42 (95% CI 0.21 to 0.84; p=0.01).

KenyaVIH/sidapublié 2026BMJ global healthPubMeddocument de 9 observations

615 inhabitantsBetween March 2018 and March 2019, 615 HIV-negative women contributed 1,128 visits (502 initiation and 626 follow-up) in a PrEP implementation study in Kisumu county, Kenya.

KenyaVIH/sidaobservé March 2018 to March 2019publié 2021PloS onePubMeddocument de 8 observations

2,9 %Biobehavioral intervention at disco matanga could avert 2.9% of HIV infections in the Nyanza region of Kenya.

KenyaVIH/sidapublié 2025BMC medicinePubMeddocument de 8 observations

19,6 %Hypertension prevalence among HIV-positive adults in Busia County was 19.6%.

Kenyahypertension artérielle · VIH/sidaobservé 2020publié 2022The Pan African medical journalPubMeddocument de 7 observations

9,24 USD_per_client_monthThe estimated financial cost per client-month on PEP was $9.24 USD for non-subsidized delivery.

KenyaVIH/sidapublié 2025BMC health services researchPubMeddocument de 13 observations

95 %Uptake of antiretroviral therapy among TB/HIV co-infected patients was 95%.

Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations

5,3 %Among 208 HIV-infected ART-naïve adults in Kenya, 11 (5.3%) had occult hepatitis B virus (OBI) infection.

Kenyahépatite B · VIH/sidapublié 2021PloS onePubMeddocument de 7 observations

9 539 infantsA total of 9539 infants received early infant diagnosis tests: 5115 laboratory-based and 4424 point-of-care.

KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations

0,002 p_valueCHEU exhibited lower levels of macrophage migration inhibitory factor (MIF) compared to CHU, with a p-value of 0.002.

KenyaVIH/sidapublié 2025AIDS (London, England)PubMeddocument de 5 observations

67 %Most of the anaemia was dimorphic in HIV-positive injection substance users (67%).

Kenyaanémie · VIH/sidapublié 2022African health sciencesPubMeddocument de 7 observations

4,1 aORNever having tested for HIV was associated with recent HIV infection with an adjusted odds ratio of 4.1.

KenyaVIH/sidapublié 2023AIDS research and human retrovirusesPubMeddocument de 7 observations

95,7 %Among 208 HIV-infected ART-naïve adults in Kenya, 199 (95.7%) did not report hepatitis B virus (HBV) vaccination.

Kenyahépatite B · VIH/sidapublié 2021PloS onePubMeddocument de 7 observations

97 %In the Standard APS arm, 97.0% (225/232) of newly diagnosed partners were linked to care.

KenyaVIH/sidaobservé 2021publié 2024Journal of the International AIDS SocietyPubMeddocument de 15 observations

2,5 %Between 2017 and 2020, 37 (2.5%) out of 1500 participants in the intervention period were diagnosed with HIV infection.

KenyaVIH/sidaobservé 2017 and 2020publié 2022HIV medicinePubMeddocument de 6 observations

1,3 aRRAntiretroviral therapy initiation among adolescents and young adults living with HIV aged 15–19 years was associated with a 30% higher adjusted risk ratio of viral suppression compared to initiation before age 10.

KenyaVIH/sidapublié 2022The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument de 5 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.